The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients with Symptomatic Peripheral Vascular Disease from Stenosis or Occlusion of the Femoropopliteal Artery
A Clinical Evaluation of the Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients with Symptomatic Peripheral Vascular Disease from Stenosis or Occlusion of the Femoropopliteal Artery
Sponsor: Efemoral Medical, Inc.
Listed as NCT04584632, this NA trial focuses on Femoropopliteal Stenosis and Peripheral Arterial Disease and remains actively recruiting participants. Sponsored by Efemoral Medical, Inc., it has been updated 8 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
8 versions recorded-
Mar 2025 — Present [monthly]
Recruiting NA
-
Sep 2024 — Mar 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jul 2024 [monthly]
Recruiting NA
-
Oct 2023 — Dec 2023 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
May 2022 — Oct 2023 [monthly]
Recruiting NA
-
Jan 2021 — May 2022 [monthly]
Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Sep 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Efemoral Medical, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Auckland, New Zealand
- • Christchurch, New Zealand
- • Hamilton, New Zealand
- • Sydney, Australia